| Typicality: | 0.211 |
| Saliency: | 0.115 |
| in a series of clinical trials | 3 | location |
| implant → be shown to be → safe | 4 |
| implant → be proven to be → safe | 3 |
| negative | neutral | positive |
| 0.010 | 0.175 | 0.816 |
| Raw frequency | 7 |
| Normalized frequency | 0.115 |
| Modifier score | 0.500 |
| Perplexity | 60.878 |